Consolidated Statements of Cash Flows (USD $)	6 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Cash flows from operating activities:
Net loss	$ (298,389)	$ (259,920)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Other Income (Expense) Equity earnings (loss) on MIT China Joint Venture	(134,490)	(104,607)
Depreciation and amortization expense	65,394	64,272
Common stock issued for services
Related party payables settle by common stock
Capitalization of related party debts
Changes in:
Accounts receivable	17,822	27,314
Inventories	(5,821)	23,553
Prepaid expenses	10,020	6,512
Accounts payable and accrued liabilities	33,323	(36,470)
Deferred income	(43,292)	138,864
Net cash used by operating activities	(86,453)	68,732
Cash flows from investing activities:
Acquisition of patents	(3,840)	(17,040)
Investment in MIT China joint venture
Tooling and machinery		(48,671)
Net cash used by investing activities	(3,840)	(65,711)
Cash flows from financing activities:
Bank line	(101,660)	23,345
Bank loans	(30,707)	50,330
Proceeds from issuance of stock, net		63,340
Increase in amounts due to related parties		(152,722)
Issuance of notes payable
Repayment on notes payable
Net cash provided from financing activities	(132,367)	(15,707)
Effect of exchange rates	2,651	1,797
Increase (decrease) in cash	(220,009)	(10,889)
Cash, beginning of period	303,497	10,889
Cash, end of period	83,488
Supplemental disclosure of cash flow information:
Cash paid for interest	8,852	35,024
Cash paid for federal income taxes
Supplemental disclosure of non-cash transactions
Common stock issued for debt reductions